ZYME
Zymeworks Inc.
Latest News for ZYME
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zymeworks (ZYME – Research Report), MBX Biosciences, Inc. (MBX – ......
Zymeworks ( ($ZYME) ) just unveiled an update. In its third-quarter 2025 update, Zymeworks reported significant progress in its clinical trials and......
TD Cowen analyst Yaron Werber reiterated a Buy rating on Zymeworks today. The company’s shares opened today at $17.45. Werber covers the Healthcare......
Zymeworks ( ($ZYME) ) just unveiled an update. Zymeworks announced promising preliminary results from its Phase 1 trial of ZW191, an antibody-drug ......
An announcement from Zymeworks ( ($ZYME) ) is now available. Zymeworks announced the presentation of preliminary data from its Phase 1 trial of ZW1......
In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Zymeworks, with a price target of $32.00. The company’s sha......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZYME | $16.46 | -8.0% | 1.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |